glp-1 obesity drug updates Agonists Weight Loss Drugs Market Report, 2025-2030 GLP-1 anti-obesity drugs lead to

Drug Discov Today

Ralston NVC, Raymond LJ (2018) Mercurys neurotoxicity is characterized by its disruption of selenium biochemistry

Misconception 4: the CASTA trial proved cerebrolysin does not work for stroke The CASTA trial showed no overall benefit in the primary endpoint for the full population, but did show benefit in severe strokes

Tirzepatide, a dual agonist for GLP-1 and GIP receptors, effectively promotes weight loss and improves metabolic parameters by influencing insulin secretion, appetite regulation, and gastric emptying

A comparison of 30-day versus 90-day proton pump inhibitor therapy in prevention of marginal ulcers after laparoscopic Roux-en-Y gastric bypass

They wondered whether antibiotics caused side effects by triggering oxidative stress in the mitochondria, a bacterium-like organelle that supplies human cells with energy